Bilimoria KY, et al. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249(1):63–71.
Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2013;63(1):11–30.
Lowenfels AB. Why are small-bowel tumours so rare? Lancet. 1973;1(7793):24–6.
Wattenberg LW. Studies of polycyclic hydrocarbon hydroxylases of the intestine possibly related to cancer. Effect of diet on benzpyrene hydroxylase activity. Cancer. 1971;28(1):99–102.
Calman KC. Why are small bowel tumours rare? An experimental model. Gut. 1974;15(7):552–4.
Moore KL. Clinically oriented anatomy. 5th ed. Baltimore: Lippincott Williams and Wilkins; 2006.
Dabaja BS, et al. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101(3):518–26.
Cobrin GM, Pittman RH, Lewis BS. Increased diagnostic yield of small bowel tumors with capsule endoscopy. Cancer. 2006;107(1):22–7.
Yamamoto H, et al. Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest Endosc. 2001;53(2):216–20.
Yamamoto H, et al. Clinical outcomes of double-balloon endoscopy for the diagnosis and treatment of small-intestinal diseases. Clin Gastroenterol Hepatol. 2004;2(11):1010–6.
Lo SK, Mehdizadeh S. Therapeutic uses of double-balloon enteroscopy. Gastrointest Endosc Clin N Am. 2006;16(2):363–76.
Boudreaux JP, et al. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas. 2010;39(6):753–66.
Feig BW, Ching CD. The MD Anderson surgical oncology handbook. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2012.
Howe JR, et al. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer. 1999;86(12):2693–706.
Overman MJ, et al. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. Acta Oncol. 2010;49(4):474–9.
Hellman P, et al. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg. 2002;26(8):991–7.
Dematteo RP, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;373(9669): 1097–104.
Joensuu H, et al. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA. 2012;307(12): 1265–72.
Koniaris LG, et al. Management of gastrointestinal lymphoma. J Am Coll Surg. 2003;197(1):127–41.